The pharmaceutical company Crossject fell 1.5% to 5.20 euros, while Invest Securities adjusted its target from 6.4 to 6.3 euros while remaining a purchase on the file. The benefits provided by the company’s Zeneo needle-free device,…
©2024 Boursier.com